Home › Calculator › LEXX Dividend Calculator 2026
LEXX Dividend DRIP Calculator 2026
21.34% YieldHealthcareLexaria Bioscience Corp. · NASDAQ
Price: $9.37 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When LEXX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your LEXX snowball 📈
$10,000 in LEXX → $1352751.05M in 10 years · $112,215,844,858.15/month
About Lexaria Bioscience Corp. (LEXX) — Dividend Analysis 2026
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technology is currently under evaluation for its potential application with orally administered antiviral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and various other compounds. A notable feature of DehydraTECH is its capacity to facilitate the passage of drugs across the blood-brain barrier. The company operates a licensed internal research facility and holds a substantial intellectual property portfolio, comprising 23 granted patents and roughly 50 pending patent applications globally. Founded in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.
Compare LEXX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full LEXX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LEXX position with:
🌍 LEXX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold LEXX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 21.34% | 18.54% | $2,134 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 18.14% | 15.34% | $1,814 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 17.07% | 14.27% | $1,707 / yr |
| 🇬🇧 UK ISA | 0% | 21.34% | 18.54% | $2,134 / yr |
| 🇬🇧 UK Taxable | 8.75% | 19.47% | 16.67% | $1,947 / yr |
| 🇨🇦 TFSA | 0% | 21.34% | 18.54% | $2,134 / yr |
| 🇨🇦 CA Taxable | 25% | 16.00% | 13.20% | $1,601 / yr |
| 🇦🇺 Super (pension) | 15% | 18.14% | 15.34% | $1,814 / yr |
| 🇦🇺 AU Taxable | 30% | 14.94% | 12.14% | $1,494 / yr |
| 🇩🇪 DE Taxable | 26.375% | 15.71% | 12.91% | $1,571 / yr |
| 🇫🇷 FR Taxable | 30% | 14.94% | 12.14% | $1,494 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 LEXX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 LEXX Dividend Payment Schedule
LEXX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 LEXX vs Healthcare Benchmarks
How LEXX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LEXX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ LEXX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| G-Gift | 2026-03-17 | 100,000 | — | — | ||
| Buy | 2025-07-30 | 11,900 | $0.91 | $10.9K | ||
| Buy | 2025-07-29 | 15,600 | $0.92 | $14.4K | ||
| Buy | 2025-07-29 | 5,000 | $0.91 | $4.5K | ||
| Buy | 2025-07-29 | 5,376 | $0.93 | $5.0K | ||
| Buy | 2025-07-29 | 750 | $0.91 | $683.00 | ||
| Buy | 2025-07-29 | 15,000 | $0.91 | $13.6K | ||
| A-Award | 2025-05-15 | 150,000 | $1.04 | $156.0K | ||
| A-Award | 2025-05-15 | 11,000 | $1.04 | $11.4K | ||
| A-Award | 2025-05-15 | 15,000 | $1.04 | $15.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LEXX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Lexaria Bioscience Corp. (LEXX) is currently trading at $9.37, 91% below its 52-week high. The current dividend yield is 21.34% based on an annual payout of $2.00 per share.
LEXX (Lexaria Bioscience Corp.) — 21.34% Dividend Yield Analysis
Lexaria Bioscience Corp. (LEXX) is a healthcare stock currently trading at $9.37 with a dividend yield of 21.34%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (21.34%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.